These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Conflicts of interest between physicians and the pharmaceutical industry and special interest groups. Schetky DH Child Adolesc Psychiatr Clin N Am; 2008 Jan; 17(1):113-25, ix-x. PubMed ID: 18036482 [TBL] [Abstract][Full Text] [Related]
43. [Commercialization of the medical research is a reality. What is the limit?]. Naeser K Ugeskr Laeger; 2005 Oct; 167(43):4103; author reply 4103-5. PubMed ID: 16251105 [No Abstract] [Full Text] [Related]
44. Pharma PR or medical education? Rentmeester CA Hastings Cent Rep; 2005; 35(2):6. PubMed ID: 15957306 [No Abstract] [Full Text] [Related]
45. [New critical questions to drug industry]. Holtedahl KA; Meland E; Klovning A Tidsskr Nor Laegeforen; 2002 Sep; 122(23):2309. PubMed ID: 12448276 [No Abstract] [Full Text] [Related]
46. [Expectations and obligations]. Haug C Tidsskr Nor Laegeforen; 2002 Jun; 122(17):1637. PubMed ID: 12555600 [No Abstract] [Full Text] [Related]
47. Yes, industry influence is excessive. Shah AA; Finucane TE Int Psychogeriatr; 2007 Dec; 19(6):1004-10; discussion 1014-20. PubMed ID: 17711608 [No Abstract] [Full Text] [Related]
48. [Promoting research and graduate education by the pharmaceutical industry--scientific progress or marketing strategy?]. Eckardt VF Z Gastroenterol; 1999 Jul; Suppl 2():19-27. PubMed ID: 10472695 [No Abstract] [Full Text] [Related]
49. Full disclosure. Maxwell D Can Fam Physician; 2008 Oct; 54(10):1377-8; discussion 1378. PubMed ID: 18854458 [No Abstract] [Full Text] [Related]
50. Marketing drugs: debating the real cost. Concern about close ties between doctors and pharmaceutical firms are prompting new financial disclosure laws and education efforts. Brand R State Legis; 2008 Sep; 34(8):26-9. PubMed ID: 18754159 [No Abstract] [Full Text] [Related]
51. 'Big pharma' and psychiatry: 'the devil is in the dyad'. Anand S Aust N Z J Psychiatry; 2012 Dec; 46(12):1118-9. PubMed ID: 23212138 [No Abstract] [Full Text] [Related]
52. Receiving gifts: a conflict of interest discussion. Schwartz B J Can Dent Assoc; 2005 Sep; 71(8):561-2. PubMed ID: 16202193 [No Abstract] [Full Text] [Related]
53. [Knowledge on feet of clay]. Dahlqvist R Lakartidningen; 2008 May 7-13; 105(19):1405-6. PubMed ID: 18574980 [No Abstract] [Full Text] [Related]
54. "No free lunch" meets the academic journals. Hughes JA Acad Emerg Med; 2003 Jun; 10(6):691-2. PubMed ID: 12782536 [No Abstract] [Full Text] [Related]
55. [Disease-mongers]. Westin S Tidsskr Nor Laegeforen; 2002 Jun; 122(17):1638. PubMed ID: 12555601 [No Abstract] [Full Text] [Related]
56. Self-ligation is not a scientific concept. Bach RM Am J Orthod Dentofacial Orthop; 2009 Dec; 136(6):757-8. PubMed ID: 19962585 [No Abstract] [Full Text] [Related]
57. Why self-regulation does not work: resolving prescription corruption caused by excessive gift-giving by pharmaceutical manufacturers. Mehta RS Food Drug Law J; 2008; 63(4):799-821. PubMed ID: 19593922 [No Abstract] [Full Text] [Related]
58. The ethics of advertising strategies in the pharmaceutical industry. Reuter L Ethics Med; 2003; 19(3):171-5. PubMed ID: 14700051 [No Abstract] [Full Text] [Related]
59. [Research ethics--challenges in a new time]. Meland E; Holtedahl KA Tidsskr Nor Laegeforen; 2002 Oct; 122(24):2348. PubMed ID: 12448245 [No Abstract] [Full Text] [Related]
60. Industry support questioned. Bornfeld M J Am Dent Assoc; 2007 Feb; 138(2):150. PubMed ID: 17272366 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]